APA (7th ed.) Citation

BP, E., & 3rd, P. J. (2022). Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients. Antimicrobial agents and chemotherapy, 66(8), e0076622. https://doi.org/10.1128/aac.00766-22

Chicago Style (17th ed.) Citation

BP, Epling, and Powers JH 3rd. "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients." Antimicrobial Agents and Chemotherapy 66, no. 8 (2022): e0076622. https://doi.org/10.1128/aac.00766-22.

MLA (9th ed.) Citation

BP, Epling, and Powers JH 3rd. "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients." Antimicrobial Agents and Chemotherapy, vol. 66, no. 8, 2022, p. e0076622, https://doi.org/10.1128/aac.00766-22.